{
    "physical_examinations": [
        {
            "date": "October 2000",
            "vital_signs": {
                "blood_pressure": "Not specified",
                "heart_rate": "Not specified",
                "respiratory_rate": "Not specified",
                "temperature": "Not specified"
            },
            "relevant_findings": {
                "left_ventricular_wall_thickness": "Mean LVWT of 21 mm (range: 15–46 mm)",
                "peak_resting_gradient": "60.4 mmHg (range: 4–231 mmHg)",
                "NYHA_functional_class": "Mean of 1.9 (0.8), with 27 patients in class 3 or 4"
            },
            "changes_over_time": "Not specified"
        },
        {
            "date": "Not specified",
            "vital_signs": {
                "blood_pressure": "Not specified",
                "heart_rate": "Not specified",
                "respiratory_rate": "Not specified",
                "temperature": "Not specified"
            },
            "relevant_findings": {
                "patient_case_1": {
                    "age": 9,
                    "max_septal_thickness": "29 mm",
                    "gradient": "75 mmHg at rest"
                },
                "patient_case_2": {
                    "age": "5 years",
                    "gradient": "Not specified"
                },
                "patient_case_3": {
                    "age": 29,
                    "gradient": "140 mmHg at rest"
                },
                "patient_case_4": {
                    "age": 38,
                    "gradient": "92 mmHg",
                    "left_ventricular_wall_thickness": "28 mm"
                },
                "patient_case_5": {
                    "age": 44,
                    "gradient": "40 mmHg",
                    "left_ventricular_wall_thickness": "21 mm"
                }
            },
            "changes_over_time": "Patient case 1 experienced progressive dyspnea, angina, and presyncope unresponsive to pharmacological therapy over 2 years, later requiring orthotopic heart transplantation at age 16 due to end-stage heart failure."
        }
    ]
}